Trailing-twelve-month (TTM) revenue is $3.41 Billion with a year-over-year growth of (0.19%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $943,168,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $1,069,673,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-03-31 | $779,013,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $614,362,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $3,406,216,000 |
Current P/S: $2,923,975,240 market capitalization ÷ $3,406,216,000 TTM revenue = 0.86x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:05:20.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $614.36M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:06:14.290Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Apparel Accessories And Equipment | $1.9B | $2.4B | $2.7B | $2.7B | $2.7B | $2.7B |
| Footwear | $634M | $737M | $803M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CANADA | $174M | $219M | $249M | $257M | $228M | $230M |
| EMEA | $299M | $382M | $439M | $469M |
$3.41B
$3.41 Billion
(0.19%)
vs. $3.41B a year ago (TTM)
+3.93%
5 Year compound annual growth rate
1 Year
(0.19%)
3 Year
(1.52%)
5 Year
+3.93%
10 Year
+3.65%
15 Year
+5.33%
20 Year
+5.37%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.40B | +$28.44M | +0.84% |
| 2024 | $3.37B | ($118.62M) | (3.40%) |
| 2023 | $3.49B | +$23.05M | +0.67% |
| 2022 | $3.46B | +$337.75M | +10.80% |
| 2021 | $3.13B | +$624.85M | +24.98% |
| 2020 |
TTM Growth
(0.19%)
3-Year CAGR
(1.52%)
5-Year CAGR
+3.93%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:06:14.290Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $681M |
| $685M |
| $577M |
| Latin America And Asia Pacific | $424M | $465M | $474M | $520M | $561M | $611M |
|---|
| UNITED STATES | $1.6B | $2.1B | $2.3B | $2.2B | $2.1B | $2.0B |
|---|
| $2.50B |
| ($540.92M) |
| (17.78%) |
| 2019 | $3.04B | +$240.15M | +8.57% |
| 2018 | $2.80B | +$336.22M | +13.63% |
| 2017 | $2.47B | +$89.06M | +3.75% |
| 2016 | $2.38B | +$50.87M | +2.19% |
